154 related articles for article (PubMed ID: 29666426)
1. Cardiac hypertrophy limits infarct expansion after myocardial infarction in mice.
Iismaa SE; Li M; Kesteven S; Wu J; Chan AY; Holman SR; Calvert JW; Haq AU; Nicks AM; Naqvi N; Husain A; Feneley MP; Graham RM
Sci Rep; 2018 Apr; 8(1):6114. PubMed ID: 29666426
[TBL] [Abstract][Full Text] [Related]
2. Myocardial connective tissue growth factor (CCN2/CTGF) attenuates left ventricular remodeling after myocardial infarction.
Gravning J; Ørn S; Kaasbøll OJ; Martinov VN; Manhenke C; Dickstein K; Edvardsen T; Attramadal H; Ahmed MS
PLoS One; 2012; 7(12):e52120. PubMed ID: 23284892
[TBL] [Abstract][Full Text] [Related]
3. Increased C-reactive protein expression exacerbates left ventricular dysfunction and remodeling after myocardial infarction.
Takahashi T; Anzai T; Kaneko H; Mano Y; Anzai A; Nagai T; Kohno T; Maekawa Y; Yoshikawa T; Fukuda K; Ogawa S
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1795-804. PubMed ID: 20852043
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
[TBL] [Abstract][Full Text] [Related]
5. Pressure overload by suprarenal aortic constriction in mice leads to left ventricular hypertrophy without c-Kit expression in cardiomyocytes.
Nicks AM; Kesteven SH; Li M; Wu J; Chan AY; Naqvi N; Husain A; Feneley MP; Smith NJ; Iismaa SE; Graham RM
Sci Rep; 2020 Sep; 10(1):15318. PubMed ID: 32948799
[TBL] [Abstract][Full Text] [Related]
6. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
[TBL] [Abstract][Full Text] [Related]
8. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
[TBL] [Abstract][Full Text] [Related]
9. Spacial and Temporal Patterns of Gene Expression After Cardiac MEK1 Gene Transfer Improve Post-Infarction Remodeling Without Inducing Global Hypertrophy.
Fan Y; Yang YL; Yeh CC; Mann MJ
J Cell Biochem; 2017 Apr; 118(4):775-784. PubMed ID: 27639174
[TBL] [Abstract][Full Text] [Related]
10. c-kit is required for cardiomyocyte terminal differentiation.
Li M; Naqvi N; Yahiro E; Liu K; Powell PC; Bradley WE; Martin DI; Graham RM; Dell'Italia LJ; Husain A
Circ Res; 2008 Mar; 102(6):677-85. PubMed ID: 18258857
[TBL] [Abstract][Full Text] [Related]
11. Lower risk of postinfarct rupture in mouse heart overexpressing beta 2-adrenergic receptors: importance of collagen content.
Gao XM; Dilley RJ; Samuel CS; Percy E; Fullerton MJ; Dart AM; Du XJ
J Cardiovasc Pharmacol; 2002 Oct; 40(4):632-40. PubMed ID: 12352327
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.
Booij HG; Yu H; De Boer RA; van de Kolk CW; van de Sluis B; Van Deursen JM; Van Gilst WH; Silljé HH; Westenbrink BD
Cardiovasc Res; 2016 Aug; 111(3):217-26. PubMed ID: 27302402
[TBL] [Abstract][Full Text] [Related]
13. MEK1-induced physiological hypertrophy inhibits chronic post-myocardial infarction remodeling in mice.
Yeh CC; Malhotra D; Yang YL; Xu Y; Fan Y; Li H; Mann MJ
J Cell Biochem; 2013 Jan; 114(1):47-55. PubMed ID: 22821618
[TBL] [Abstract][Full Text] [Related]
14. Heat-shock transcription factor 1 is critically involved in the ischaemia-induced cardiac hypertrophy via JAK2/STAT3 pathway.
Yuan L; Qiu L; Ye Y; Wu J; Wang S; Wang X; Zhou N; Zou Y
J Cell Mol Med; 2018 Sep; 22(9):4292-4303. PubMed ID: 29992755
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of calpastatin inhibits calpain activation and attenuates post-infarction myocardial remodeling.
Ye T; Wang Q; Zhang Y; Song X; Yang D; Li D; Li D; Su L; Yang Y; Ma S
PLoS One; 2015; 10(3):e0120178. PubMed ID: 25786109
[TBL] [Abstract][Full Text] [Related]
16. A new model of congestive heart failure in rats.
Chen J; Chemaly ER; Liang LF; LaRocca TJ; Yaniz-Galende E; Hajjar RJ
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H994-1003. PubMed ID: 21685270
[TBL] [Abstract][Full Text] [Related]
17. c-kit dysfunction impairs myocardial healing after infarction.
Cimini M; Fazel S; Zhuo S; Xaymardan M; Fujii H; Weisel RD; Li RK
Circulation; 2007 Sep; 116(11 Suppl):I77-82. PubMed ID: 17846329
[TBL] [Abstract][Full Text] [Related]
18. Calpastatin overexpression impairs postinfarct scar healing in mice by compromising reparative immune cell recruitment and activation.
Wan F; Letavernier E; Le Saux CJ; Houssaini A; Abid S; Czibik G; Sawaki D; Marcos E; Dubois-Rande JL; Baud L; Adnot S; Derumeaux G; Gellen B
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1883-93. PubMed ID: 26453333
[TBL] [Abstract][Full Text] [Related]
19. Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA.
Barandon L; Couffinhal T; Ezan J; Dufourcq P; Costet P; Alzieu P; Leroux L; Moreau C; Dare D; Duplàa C
Circulation; 2003 Nov; 108(18):2282-9. PubMed ID: 14581414
[TBL] [Abstract][Full Text] [Related]
20. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
